Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Surgery
Volume 2016 (2016), Article ID 4548798, 5 pages
http://dx.doi.org/10.1155/2016/4548798
Case Report

Successful Resection of Isolated Para-Aortic Lymph Node Recurrence from Advanced Sigmoid Colon Cancer following 156 Courses of FOLFIRI Regimen

Department of Surgery, Saitama City Hospital, Saitama 336-0911, Japan

Received 25 May 2016; Revised 28 July 2016; Accepted 3 August 2016

Academic Editor: Paola De Nardi

Copyright © 2016 Kaoru Takeshima et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. S. Min, N. K. Kim, S. K. Sohn, C. H. Cho, K. Y. Lee, and S. H. Baik, “Isolated paraaortic lymph-node recurrence after the curative resection of colorectal carcinoma,” Journal of Surgical Oncology, vol. 97, no. 2, pp. 136–140, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. M.-S. Kim, C. K. Cho, K. M. Yang, D. H. Lee, S. M. Moon, and Y. J. Shin, “Stereotactic body radiotherapy for isolated paraaortic lymph node recurrence from colorectal cancer,” World Journal of Gastroenterology, vol. 15, no. 48, pp. 6091–6095, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. R. G. Landmann and M. R. Weiser, “Surgical management of locally advanced and locally recurrent colon cancer,” Clinics in Colon and Rectal Surgery, vol. 18, no. 3, pp. 182–189, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Tournigand, T. André, E. Achille et al., “FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study,” Journal of Clinical Oncology, vol. 22, no. 2, pp. 229–237, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. L. H. Sobin, M. K. Gospodarowicz, and C. Wittekind, International Union against Cancer: Tnm Classification of Malignant Tumours, Union for International Cancer Control, West Sussex, UK, 7th edition, 2010.
  6. E. A. Eisenhauer, P. Therasse, J. Bogaerts et al., “New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1),” European Journal of Cancer, vol. 45, no. 2, pp. 228–247, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Chau and D. Cunningham, “Treatment in advanced colorectal cancer: what, when and how?” British Journal of Cancer, vol. 100, no. 11, pp. 1704–1719, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. C. J. H. van de Velde, P. G. Boelens, J. M. Borras et al., “EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum,” European Journal of Cancer, vol. 50, no. 1, pp. 1.e1–1.e34, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Shibata, P. B. Paty, J. G. Guillem, W. D. Wong, and A. M. Cohen, “Surgical management of isolated retroperitoneal recurrences of colorectal carcinoma,” Diseases of the Colon and Rectum, vol. 45, no. 6, pp. 795–801, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. W. B. Bowne, B. Lee, W. D. Wong et al., “Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 cases,” Diseases of the Colon and Rectum, vol. 48, no. 5, pp. 897–909, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Ogura, T. Akiyoshi, Y. Takatsu et al., “The significance of extended lymphadenectomy for colorectal cancer with isolated synchronous extraregional lymph node metastasis,” Asian Journal of Surgery, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. S. U. Bae, Y. D. Han, M. S. Cho et al., “Oncologic outcomes of colon cancer patients with extraregional lymph node metastasis: comparison of isolated paraaortic lymph node metastasis with resectable liver metastasis,” Annals of Surgical Oncology, vol. 23, no. 5, pp. 1562–1568, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Yasuda, H. Kamata, T. Machida et al., “A case of isolated paraaortic lymph node recurrence from colon cancer successfully treated with chemoradiotherapy,” The Tokai Journal of Experimental and Clinical Medicine, vol. 37, no. 2, pp. 47–50, 2012. View at Google Scholar · View at Scopus
  14. Nordic Gastrointestinal Tumor Adjuvant Therapy Group, “Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial,” Journal of Clinical Oncology, vol. 10, no. 6, pp. 904–911, 1992. View at Google Scholar · View at Scopus
  15. S. P. Ackland, M. Jones, D. Tu et al., “A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancer,” British Journal of Cancer, vol. 93, no. 11, pp. 1236–1243, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Mandalà, S. Barni, I. Floriani et al., “Incidence and clinical implications of venous thromboembolism in advanced colorectal cancer patients: the ‘GISCAD-alternating schedule’ study findings,” European Journal of Cancer, vol. 45, no. 1, pp. 65–73, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Araujo, M. Gonen, P. Allen et al., “Comparison between perioperative and postoperative chemotherapy after potentially curative hepatic resection for metastatic colorectal cancer,” Annals of Surgical Oncology, vol. 20, no. 13, pp. 4312–4321, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. H. I. Hurwitz, W. Honeycutt, S. Haley, and J. Favaro, “Long-term treatment with bevacizumab for patients with metastatic colorectal cancer: case report,” Clinical Colorectal Cancer, vol. 6, no. 1, pp. 66–69, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Seront, L. Marot, E. Coche, J.-L. Gala, C. Sempoux, and Y. Humblet, “Successful long-term management of a patient with late-stage metastatic colorectal cancer treated with panitumumab,” Cancer Treatment Reviews, vol. 36, supplement 1, pp. S11–S14, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Minami, K. Sai, M. Saeki et al., “Irinotecan pharmacokinetics/pharmacodynamics and UGT1A genetic polymorphisms in Japanese: roles of UGT1A1*6 and *28,” Pharmacogenetics and Genomics, vol. 17, no. 7, pp. 497–504, 2007. View at Publisher · View at Google Scholar · View at Scopus